trending Market Intelligence /marketintelligence/en/news-insights/trending/qwkZ2oHMFPUArbCFb0y2wQ2 content esgSubNav
In This List

Boston Biomedical appoints chief medical officer, chief commercial officer

Blog

Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in

Blog

A Cloud Migration Plan for Corporations featuring Snowflake®

Blog

Investor Activism Campaigns Hit Record High in 2022

Blog

Essential IR Insights Newsletter - February 2023


Boston Biomedical appoints chief medical officer, chief commercial officer

Boston Biomedical Inc. appointed Edgar Braendle as executive vice president, head of research and development and chief medical officer.

Braendle previously served as president and CEO of ARUP Laboratories, a national clinical and anatomic pathology reference laboratory.

The company also appointed Dee Mahoney as senior vice president and chief commercial officer.

Mahoney was previously the co-founder and president of DMH BioPharm Advisors, a boutique management consultancy.

Boston Biomedical is owned by Sumitomo Dainippon Pharma Co. Ltd.